Your browser is no longer supported. Please, upgrade your browser.
Opiant Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.46 Insider Own3.30% Shs Outstand4.26M Perf Week-2.31%
Market Cap54.11M Forward P/E- EPS next Y-5.05 Insider Trans-15.73% Shs Float3.97M Perf Month13.72%
Income-1.90M PEG- EPS next Q-0.71 Inst Own24.20% Short Float0.49% Perf Quarter4.16%
Sales29.60M P/S1.83 EPS this Y-120.20% Inst Trans0.28% Short Ratio0.66 Perf Half Y78.60%
Book/sh8.34 P/B1.47 EPS next Y-227.90% ROA-4.10% Target Price- Perf Year6.55%
Cash/sh10.95 P/C1.12 EPS next 5Y- ROE-5.40% 52W Range6.79 - 14.98 Perf YTD52.80%
Dividend- P/FCF- EPS past 5Y36.00% ROI-3.30% 52W High-18.07% Beta0.75
Dividend %- Quick Ratio9.20 Sales past 5Y24.50% Gross Margin79.10% 52W Low80.77% ATR0.58
Employees30 Current Ratio9.20 Sales Q/Q28.60% Oper. Margin-7.60% RSI (14)60.12 Volatility3.98% 5.03%
OptionableNo Debt/Eq0.53 EPS Q/Q-182.10% Profit Margin-6.30% Rel Volume0.51 Prev Close12.25
ShortableYes LT Debt/Eq0.53 EarningsMar 04 AMC Payout- Avg Volume29.36K Price12.27
Recom2.00 SMA208.35% SMA505.74% SMA20028.15% Volume14,951 Change0.16%
May-29-19Initiated Northland Capital Outperform
May-03-21 04:01PM  
Apr-05-21 04:01PM  
Mar-31-21 04:01PM  
Mar-22-21 04:01PM  
Mar-09-21 06:25AM  
Mar-06-21 02:11AM  
Mar-04-21 04:48PM  
Feb-22-21 04:01PM  
Feb-12-21 07:15AM  
Feb-09-21 11:30AM  
Feb-08-21 04:01PM  
Dec-15-20 07:52AM  
Dec-14-20 04:01PM  
Dec-10-20 04:01PM  
Dec-07-20 04:01PM  
Nov-27-20 09:58AM  
Nov-17-20 06:16AM  
Nov-12-20 04:41PM  
Nov-02-20 04:01PM  
Oct-29-20 04:05PM  
Oct-27-20 04:01PM  
Sep-21-20 09:56AM  
Sep-14-20 09:46AM  
Aug-31-20 04:05PM  
Aug-24-20 03:50PM  
Aug-17-20 11:46AM  
Aug-10-20 07:45AM  
Aug-06-20 04:05PM  
Jul-23-20 04:01PM  
Jun-30-20 07:08PM  
Jun-08-20 04:14PM  
Jun-07-20 03:36AM  
Jun-05-20 09:37PM  
Jun-04-20 06:40PM  
May-26-20 04:05PM  
May-25-20 12:59PM  
May-21-20 04:05PM  
May-15-20 06:06AM  
May-12-20 04:05PM  
Apr-28-20 08:00AM  
Mar-26-20 02:57PM  
Mar-25-20 11:09PM  
Mar-09-20 07:15AM  
Mar-04-20 04:05PM  
Feb-24-20 04:01PM  
Jan-24-20 09:32AM  
Jan-06-20 04:26PM  
Jan-02-20 08:00AM  
Dec-12-19 04:05PM  
Dec-10-19 12:07PM  
Nov-24-19 04:25PM  
Nov-13-19 08:40AM  
Nov-12-19 04:05PM  
Nov-05-19 08:00AM  
Oct-14-19 02:14PM  
Oct-10-19 08:00AM  
Sep-24-19 04:05PM  
Sep-17-19 08:00AM  
Sep-12-19 11:25AM  
Aug-27-19 04:30PM  
Aug-19-19 06:02PM  
Aug-13-19 10:10AM  
Aug-08-19 04:05PM  
Jul-30-19 04:30PM  
Jul-29-19 01:04PM  
Jul-23-19 08:00AM  
Jun-14-19 01:44PM  
May-25-19 07:25AM  
May-13-19 12:45PM  
May-09-19 04:05PM  
Apr-30-19 04:05PM  
Apr-28-19 09:53AM  
Apr-15-19 11:45AM  
Apr-12-19 10:13AM  
Apr-08-19 08:00AM  
Apr-03-19 08:00AM  
Apr-01-19 08:00AM  
Mar-28-19 08:00AM  
Mar-25-19 01:30PM  
Mar-21-19 04:05PM  
Mar-18-19 04:05PM  
Feb-21-19 04:05PM  
Feb-06-19 02:38PM  
Feb-01-19 11:30AM  
Jan-09-19 01:30PM  
Dec-26-18 08:00AM  
Dec-24-18 08:00AM  
Nov-20-18 11:13AM  
Nov-19-18 07:40AM  
Nov-16-18 11:56AM  
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Silver Gabrielle AlisonDirectorMar 17Option Exercise10.007,88678,86023,635Mar 17 04:51 PM
MacDougall Ann L.DirectorMar 17Option Exercise10.007,27972,79027,444Mar 17 04:53 PM
MacDougall Ann L.DirectorMar 17Sale11.076,60673,12820,838Mar 17 04:53 PM
Silver Gabrielle AlisonDirectorMar 17Sale11.077,15779,22816,478Mar 17 04:51 PM
Silver Gabrielle AlisonDirectorMar 16Option Exercise10.002,23122,31017,698Mar 17 04:51 PM
MacDougall Ann L.DirectorMar 16Option Exercise10.002,23122,31022,114Mar 17 04:53 PM
MacDougall Ann L.DirectorMar 16Sale11.501,94922,41420,165Mar 17 04:53 PM
Silver Gabrielle AlisonDirectorMar 16Sale11.501,94922,41415,749Mar 17 04:51 PM
MacDougall Ann L.DirectorMar 15Option Exercise10.006,48364,83025,483Mar 17 04:53 PM
Silver Gabrielle AlisonDirectorMar 15Option Exercise10.004,51845,18019,367Mar 17 04:51 PM
Silver Gabrielle AlisonDirectorMar 15Sale11.643,90045,39615,467Mar 17 04:51 PM
MacDougall Ann L.DirectorMar 15Sale11.635,60065,12819,883Mar 17 04:53 PM
Silver Gabrielle AlisonDirectorMar 05Option Exercise10.008,33483,34014,849Mar 08 04:02 PM
MacDougall Ann L.DirectorFeb 11Option Exercise10.007,00070,00019,000Feb 16 04:01 PM
Thomas Thomas T.DirectorSep 04Buy8.055004,0255,000Sep 08 04:01 PM
Thomas Thomas T.DirectorSep 03Buy8.402,50021,0004,500Sep 08 04:01 PM